TNNT2 and hydrops fetalis: In patients with HCM, elevated cTnT predicts clinical outcomes i.e., HF (hazard ratio 4.3 for New York Heart Association (NYHA) class II and hazard ratio 22.8 for NYHA class III), atrial fibrillation, and death [26].